Insulin Augmentation of 17α-Hydroxylase Activity Is Mediated by Phosphatidyl Inositol 3-Kinase but Not Extracellular Signal-Regulated Kinase-1/ 2 in Human Ovarian Theca Cells

Endocrinology

Volumn 145, Issue 1, 2004, Pages 175-183

  Munir, Iqbal ^a   Yen, Hui Wen ^a   Geller, David H ^a   Torbati, Donna ^a   Bierden, Rebecca M ^a   Weitsman, Stacy R ^a   Agarwal, Sanjay K ^a   Magoffin, Denis A ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 MORPHOLINO 8 PHENYLCHROMONE; FORSKOLIN; INSULIN; INSULIN RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; NEUTRALIZING ANTIBODY; PHOSPHATIDYLINOSITOL 3 KINASE; SOMATOMEDIN; STEROID 17ALPHA MONOOXYGENASE;

ANOVULATION; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN CELL; HYPERANDROGENISM; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN RESPONSE; OVARY CELL CULTURE; OVARY POLYCYSTIC DISEASE; PREMENOPAUSE; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; THECA CELL;

EID: 0346458803     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/en.2003-0329     Document Type: Article

References (42)

1. Legro RS, Kunselman AR, Dodson WC, Dunaif A 1999 Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women. J Clin Endocrinol Metab 84:165-169
2. Conn JJ, Jacobs HS, Conway GS 2000 The prevalence of polycystic ovaries in women with type 2 diabetes mellitus. Clin Endocrinol (Oxf) 52:81-86
3. Legro RS, Finegood D, Dunaif A 1998 A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome. J Clin Endocrinol Metab 83:2694-2698
4. Nestler JE, Jakubowicz DJ, de Vargas AF, Brik C, Quintero N, Medina F 1998 Insulin stimulates testosterone biosynthesis by human thecal cells from women with polycystic ovary syndrome by activating its own receptor and using inositol glycan mediators as the signal transduction system. J Clin Endocrinol Metab 83:2001-2005
5. Acbay O, Gundogdu S 1996 Can metformin reduce insulin resistance in polycystic ovary syndrome? Fertil Steril 65:946-949
6. Dunaif A, Scott D, Finegood D, Quintana B, Whitcomb R 1996 The insulin-sensitizing agent troglitazone improves metabolic and reproductive abnormalities in the polycystic ovary syndrome. J Clin Endocrinol Metab 81:3299-3306
7. Sattar N, Hopkinson ZE, Greer IA 1998 Insulin-sensitizing agents in polycystic ovary syndrome. Lancet 351:305-307
8. Nestler JE, Jakubowicz DJ 1997 Lean women with polycystic ovary syndrome respond to insulin reduction with decreases in ovarian P450c17 α activity and serum androgens. J Clin Endocrinol Metab 82:4075-4079
9. La Marca A, Egbe TO, Morgante G, Paglia T, Ciani A, de Leo V 2000 Metformin treatment reduces ovarian cytochrome P-450c17 response to human chorionic gonadotrophin in woen with insulin resistance-polycystic ovary syndrome. Hum Reprod 15:21-23
10. Saltiel AR, Olefsky JM 1996 Thiazolidinediones in the treatment of insulin resistance and type II diabetes. Diabetes 45:1661-1669
11. Hasegawa I, Murakawa H, Suzuki M, Yamamoto Y, Kurabayashi T, Tanaka K 1999 Effect of troglitazone on endocrine and ovulatory performance in women with insulin resistance-related polycystic ovary syndrome. Fertil Steril 71:323-327
12. Talbot JA, Bicknell EJ, Rajkhowa M, Krook A, O'Rahilly S, Clayton RN 1996 Molecular scanning of the insulin receptor gene in women with polycystic ovarian syndrome. J Clin Endocrinol Metab 81:1979-1983
13. Ciaraldi TP, El-Roeiy A, Madar Z, Reichart D, Olefsky JM, Yen SSC 1992 Cellular mechanisms of insulin resistance in polycystic ovary syndrome. J Clin Endocrinol Metab 75:577-583
14. Ciaraldi TP, Morales AJ, Hickman MG, Odom-Ford R, Yen SSC, Olefsky JM 1998 Lack of insulin resistance in fibroblasts from subjects with polycystic ovary syndrome. Metabolism 47:940-946
15. Dunaif A, Xia J, Book C, Schenker E, Tang Z 1995 Excessive insulin receptor serine phosphorylation in cultured fibroblasts and in skeletal muscle. J Clin Invest 96:801-810
16. Dunaif A, Wu X, Lee A, Diamanti-Kandarakis E 2001 Defects in insulin receptor signaling in vivo in the polycystic ovary syndrome (PCOS). Am J Physiol Endocrinol Metab 281:E392-E399
17. Book CB, Dunaif A 1999 Selective insulin resistance in the polycystic ovary syndrome. J Clin Endocrinol Metab 84:3110-3116
18. Jakimiuk AJ, Weitsman SR, Navab A, Magoffin DA 2001 Luteinizing hormone receptor, steroidogenesis acute regulatory protein and steroidogenic enzyme messenger ribonucleic acids are over-expressed in theca and granulosa cells from polycystic ovaries. J Clin Endocrinol Metab 86:1318-1323
19. Bergh C, Carlsson B, Olsson J-H, Selleskog U, Hillensjo T 1993 Regulation of androgen production in cultured human thecal cells by insulin-like growth factor 1 and insulin. Fertil Steril 59:323-331
20. Nahum R, Thong KJ, Hillier SG 1995 Metabolic regulation of androgen production by human thecal cells in vitro. Human Reprod 10:75-81
21. Mynarcik DC, Williams PF, Schaffer L, Yu GQ, Whittaker J 1997 Identification of common ligand binding determinants of the insulin and insulin-like growth factor I receptors. Insights into mechanisms of ligand binding. J Biol Chem 272:18650-18655
22. Steele-Perkins G, Turner J, Edman JC, Hari J, Pierce SB, Stover C, Rutter WJ, Roth RA1988 Expression and characterization of a functional human insulin-like growth factor I receptor. J Biol Chem 263:11486-11492
23. Roth RA, Cassell DJ, Wong KY, Maddux BA, Goldfine ID 1982 Monoclonal antibodies to the human insulin receptor block insulin binding and inhibit insulin action. Proc Natl Acad Sci USA 79:7312-7316
24. Jacobs S, Cook S, Svoboda ME, Van Wyk JJ 1986 Interaction of the monoclonal antibodies αIR-1 and αIR-3 with insulin and somatomedin-C receptors. Endocrinology 118:223-226
25. Vlahos CJ, Matter WF, Hui KY, Brown RF 1994 A specific inhibitor of phosphatidylinositol 3-kinase, 2-(morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). J Biol Chem 269:5241-5248
26. Withers DJ, White M 2000 The insulin signaling system - a common link in the pathogenesis of type 2 diabetes. Endocrinology 141:1917-1921
27. Alessi DR, Cuenda A, Cohen P, Dudley DT, Saltiel AR 1995 PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J Biol Chem 270:27489-27494
28. Favata MF, Horiuchi KY, Manos EJ, Daulerio AJ, Stradley DA, Feeser WS, Van Dyk DE, Pitts WJ, Earl RA, Hobbs F, Copeland RA, Magolda RL, Scherle PA, Trzaskos JM 1998 Identification of a novel inhibitor of mitogen-activated protein kinase kinase. J Biol Chem 273:18623-18632
29. Franks S, Gilling-Smith C, Watson H, Willis D 1999 Insulin action in the normal and polycystic ovary. Endocrinol Metab Clin North Am 28:361-378
30. Bailyes EM, Nave BT, Soos MA, Orr SR, Hayward AC, Siddle K 1997 Insulin receptor/IGF-I receptor hybrids are widely distributed in mammalian tissues: quantification of individual receptor species by selective immunoprecipitation and immunoblotting. Biochem J 327(Pt 1):209-215
31. Morgan DO, Roth RA 1986 Identification of a monoclonal antibody which can distinguish between two distinct species of the type I receptor for insulin-like growth factor. Biochem Biophys Res Commun 138:1341-1347
32. Kull FC, Jacobs S, Su YF, Svoboda ME, Van Wyk JJ, Cuatrecasas P 1983 Monoclonal antibodies to receptors for insulin and somatomedin-C. J Biol Chem 258:6561-6566
33. Dunaif A, Segal KR, Shelley DR, Green G, Dobrjansky A, Licholai T 1992 Evidence for distinctive and intrinsic defects in insulin action in polycystic ovary syndrome. Diabetes 41:1257-1266
34. Pessin JE, Saltiel AR 2000 Signaling pathways in insulin action: molecular targets of insulin resistance. J Clin Invest 106:165-169
35. Virkamaki A, Ueki K, Kahn CR 1999 Protein-protein interaction in insulin signaling and the molecular mechanisms of insulin resistance. J Clin Invest 103:931-943
36. Guo S, Cichy SB, He X, Yang Q, Ragland M, Ghosh AK, Johnson PF, Unterman TG 2001 Insulin suppresses transactivation by CAAT/enhancer-binding proteins β (C/EPBβ). signaling to p300/CREB-binding protein by protein kinase B disrupts interaction with the major activation domain of C/EBPβ. J Biol Chem 276:8516-8523
37. Esteve PO, Chicoine E, Robledo O, Van Themsche C, Potworowski EF, St-Pierre Y 2002 Protein kinase C-ζ regulates transcription of the matrix metalloproteinase-9 gene induced by IL-1 and TNF-α in glioma cells via NF-κB. J Biol Chem 277:35150-35155
38. Rhoads RE 1999 Signal transduction pathways that regulate eukaryotic protein synthesis. J Biol Chem 274:30337-30340
39. Seger R, Hanoch T, Rosenberg R, Dantes A, Merz WE, Strauss 3rd JF, Amsterdam A 2001 The ERK signaling cascade inhibits gonadotropin-stimulated steroidogenesis. J Biol Chem 276:13957-13964
40. Sewer MB, Waterman MR 2003 cAMP-Dependent protein kinase enhances CYP17 transcription via MKP-1 activation in H295R human adrenocortical cells. J Biol Chem 278:8106-8111
41. Arlt W, Auchus RJ, Miller WL 2001 Thiazolidinediones but not metformin directly inhibit the steroidogenic enzymes P450c17 and 3beta-hydroxysteroid dehydrogenase. J Biol Chem 276:16767-16771
42. Zhang B, Szalkowski D, Diaz E, Hayes N, Smith R, Berger J 1994 Potentiation of insulin stimulation of PI3-kinase by thiazolidinedione-derived antidiabetic agents in Chinese hamster ovary cells expressing human insulin receptors and L6 myotubes. J Biol Chem 269:25735-25741